🇺🇸 FDA
Patent

US 10058602

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10058602 (Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K39/12